About
- - Company
    - About Sensus Healthcare
    - Sensus Healthcare, Inc. is a medical device company specializing in highly effective, non-invasive, minimally-invasive, and cost-effective treatments for both oncological and non-oncological conditions.
      
      Read More
  - Patient Advocates
  - FAQ
    - - What is SRT?
        We offer a painless, safe and highly effective non-surgical skin cancer treatment that is an alternative to surgery—Superficial Radiation Therapy using the SRT-100™.
        
        Go to FAQ
      - What does SRT treat?
        The SRT-100™ is an excellent treatment option for patients with the following conditions: Keloid scars, Basal cell carcinoma, Squamous cell carcinoma, Metatypical carcinoma, Cutaneous appendage carcinoma, Actinic keratosis, Kaposi’s sarcoma.
        
        Go to FAQ
      - Is SRT right for me?
        The SRT-100™ doesn’t harm surrounding or underlying healthy tissue while targeting cancer cells. The SRT-100™ provides excellent cosmetic outcomes and is a great alternative for patients with various co-morbidities.
        
        Go to FAQ
      - What should I expect?
        You should expect the same results as surgery, but with these additional benefits: No pain, No anesthesia, No cutting, No bleeding, No stitching, No scarring, No interruption of lifestyle, No reconstructive surgery
        
        Go to FAQ
      - Is the SRT-100 safe?
        The SRT-100™ is a safe and proven technology that effectively treats non-melanoma skin cancers, keloid scarring, actinic keratosis and Kaposi’s sarcoma. It is utilized by dermatologists and radiation oncologists all over the world because it delivers good patient outcomes.
        
        Go to FAQ
  - Careers
    - - Sensus - Field Service Engineer
    - View Career Opportunities
Physicians
Patients
Investors
- Corporate Governance Guidelines
- Code of Ethics and Business Conduct
Resources
Contact Us

Modern Medicine - Dr. Brian Berman discusses the problem with keloids.

Researchers found in a retrospective study of 297 surgically excised keloids with superficial radiation therapy around the excision site that only 3% recurred during an average 6-month follow-up.

Read the full article here.

Start your journey to a happy & healthy recovery.

Or search for a treatment location:

Begin Search

Sensus Healthcare World Headquarters

851 Broken Sound Pkwy NW #215 Boca Raton FL, 33487
USA Toll Free: 800-324-9890
Phone: 561-922-5808
Fax: 561-948-2071

SRT-100+™SRT 100 Vision™Clinical Photos FAQ SRT Practice Advantage

Alternative to Mohs Case Studies Basal Cell Carcinoma Squamous Cell Carcinoma Keloid

Patient Advocates Company Leadership Medical Advisory Board Careers Code of Ethics and Business Conduct Corporate Governance Guidelines Terms and Conditions Privacy Policy Cookies Policy

Videos Blog

Modern Medicine - Dr. Brian Berman discusses the problem with keloids.

Dermatology

Patients

About

Resources